Clear Passage™
$14.00
This variant is currently sold out.
Clear Passage™
Sinus & Airway Clearing · Aromatic Blend]
If you've ever used Inula, you already know. If you haven't — this is the introduction. You know the feeling: the head that won't clear, the breath that takes more effort than it should, the kind of thick mucus that weights everything and forces you to breathe through your mouth. You're not sick exactly — just completely blocked.
Clear Passage™ is a short-use aromatic blend built around Inula as its core. It is not a comfort scent, it has work to do. We've used it ourselves and found genuine relief. It's one of the formulations we return to without hesitation. The name, as you'll find, is accurate. Let us know how it performs for you.
Clear Passage™ is a legacy composition formulated by Anita Felice for the early, familiar moments when the head feels full, the sinuses feel blocked, or the breath feels constrained—not from illness, but from congestion, environmental exposure, travel fatigue, or stagnant mucus. It is designed for short, intentional use when the upper respiratory passages need support re-establishing movement and pressure relief. This blend favors precision over intensity.
Clear Passage™ supports clearance by encouraging movement—of air, mucus, and pressure—without suppressing sensation or masking discomfort. This is a situational blend, not a continuous-use formula. Use only when needed.
Formulation Logic
RESEARCH-FORMULATED™ · Formulation Logic, Applied.
Clear Passage™ begins with Inula. This is the material that gives the formula its particular purpose. In traditional European aromatherapy, Inula has long been used when mucus feels thick, lodged, and difficult to move. Its essential oil is chemically distinctive, commonly containing substantial oxygenated monoterpenes such as borneol and bornyl acetate, though proportions vary considerably by origin and batch.
Blue Gum Eucalyptus adds a different kind of respiratory support. Its characteristically high 1,8-cineole content is relevant here: cineole has been studied clinically for mucolytic and inflammatory-airway effects, while Eucalyptus itself contributes the immediate, penetrating sensation people associate with clearer breathing. The clinical cineole research doesn't test Clear Passage™ or establish the same effect from brief inhalation, but it explains why this material belongs beside Inula rather than simply adding another strong-smelling oil.
Rosemary extends the penetrating herbal middle and keeps the Inula–Eucalyptus core clear and defined.
Cinnamon contributes warmth to the composition and brings laboratory evidence of antibacterial activity against respiratory-tract organisms, including in vapor-phase testing. It is not the clearing core of the formula, but it gives the blend a different functional dimension from Inula and Eucalyptus.
That's the case for each material: traditional relevance where the evidence is thin, direct laboratory support where it exists, and nothing asked to carry more than what it has actually shown.
Questions & Answers
Why is Inula the defining ingredient in Clear Passage™?
Because the formula is built around it, not simply flavored with it. Inula is also considerably less familiar than the respiratory oils most people reach for first, which is part of why Clear Passage™ has such a distinctive character. What the material actually does is covered under Formulation Logic above.
How is Clear Passage™ different from a typical Eucalyptus respiratory blend?
Most respiratory blends are built primarily around Eucalyptus. Clear Passage™ puts Inula at the centre instead, with Eucalyptus, Rosemary, and Cinnamon supporting it. If you're after a simple, fresh respiratory scent, this is more formula than you need — reach for Clear Passage™ specifically when congestion feels dense and hard to shift.
Why does Clear Passage™ need to be used sparingly?
Because more isn't better with a formula this concentrated. It was designed as an intermittent tool — a small amount, a short exposure, then time to assess whether you need it again — rather than something to reach for continuously. See Notes and Cautions for specific guidance.
Is the "clearing" effect the same thing as a decongestant drug?
No. Clear Passage™ is an aromatic formulation, not a pharmaceutical decongestant, and the finished blend hasn't been clinically tested as one. Its purpose is aromatic respiratory support when the passages feel congested — not a replacement for medical treatment when congestion is severe, persistent, or comes with symptoms that need evaluation.
Aroma
Penetrating, crisp, and slightly warming.
Bright, cooling eucalyptus lift opens the blend, followed by herbal sharpness from rosemary and a subtle base warmth from cinnamon. Immediate and functional—designed to register quickly and then release.
Applications
Use Clear Passage™ when the head or sinuses feel congested, heavy, or blocked and clearer airflow is needed.
Diffusion
Short sessions in well-ventilated spaces.
Personal Inhalation
Indirect wafting or inhaler use — 3 inhalations with breaks is sufficient; wait approximately 30 minutes between sessions.
Topical Use
Only when properly diluted; apply away from the face and mucous membranes.
Ingredients
A concentrated aromatic blend of Inula, Rosemary, Blue Gum Eucalyptus, and Cinnamon.
Notes and Cautions
Inula is a sharp, clearing material. Used too frequently or in excess, it can be irritating to delicate nasal and sinus membranes. Approach this blend with discipline: short duration, small amounts, and only when congestion is present.
- Strong, penetrating aromatic profile.
- Designed for short-term, situational use — not a daily or continuous-use blend.
- Diffuse sparingly.
- Patch test recommended for topical application.
See Safety & Responsible Use for Ananda's general essential-oil guidance.
Lineage Note
Clear Passage™ reflects Ananda's approach to respiratory support: address congestion through clarity and movement, not suppression. It is formulated to assist the body's natural clearing rhythm when environmental exposure, travel, or seasonal conditions interfere with ease of breath.
For traditional use context and key constituent notes and formulation logic, see the Legacy Archive entry for Clear Passage™.
Further Study
The research below concerns individual materials and constituents relevant to Clear Passage™. It does not constitute clinical testing of the finished blend.
Inula — Essential-Oil Chemistry and Biological Activity
Mitić V, Stankov Jovanović V, Ilić M, Jovanović O, Djordjević A, Stojanović G. Dittrichia graveolens (L.) Greuter Essential Oil: Chemical Composition, Multivariate Analysis, and Antimicrobial Activity. Chemistry & Biodiversity. 2016;13(1):85–90.
Researchers analyzed Dittrichia graveolens essential oil by GC-FID and GC/MS and identified 54 compounds representing 92.9% of the oil. The sample was strongly dominated by oxygenated monoterpenes, particularly borneol (43.6%) and bornyl acetate (38.3%). It showed in-vitro antibacterial activity against the Gram-positive organisms tested. This study is useful for understanding Inula as a chemically distinctive and biologically active essential oil. It does not test inhaled Inula for sinus congestion or mucus clearance, and Inula chemistry can vary substantially between batches and origins.
[Add DOI/link when available.]
Inula — Activity Against Staphylococcus aureus
Guinoiseau E, Luciani A, Rossi PG, Quilichini Y, Ternengo S, Bradesi P, Berti L. Cellular effects induced by Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus. European Journal of Clinical Microbiology & Infectious Diseases. 2010;29(7):873–879.
This laboratory study tested Inula graveolens essential oil directly against Staphylococcus aureus. The oil produced bactericidal activity at the concentrations studied, and electron microscopy showed changes involving the bacterial membrane and cell wall. The study demonstrates biological activity of Inula essential oil itself rather than an isolated constituent. It remains an in-vitro antibacterial study, however; it does not establish that inhaling Inula treats respiratory infection or clinically clears congestion.
[Add DOI/link when available.]
1,8-Cineole — Human Respiratory Research
Fischer J, Dethlefsen U. Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial. Cough. 2013;9(1):25.
In this randomized, double-blind, placebo-controlled multicenter trial, 242 adults with acute bronchitis received either standardized cineole or placebo for ten days. The cineole group showed greater improvement in the bronchitis symptom score, with differences apparent after four days. This is relevant because Blue Gum Eucalyptus is characteristically rich in 1,8-cineole and helps explain why cineole-rich Eucalyptus has a meaningful place in respiratory formulations. The important distinction is route: the study used 600 mg per day of orally administered isolated cineole, not inhaled Eucalyptus essential oil and not Clear Passage™. It supports the respiratory relevance of the constituent; it does not establish equivalent clinical effects from aromatic use.
[Add DOI/link when available.]
Cinnamon and Eucalyptus — Respiratory-Pathogen Laboratory Research
Ács K, Bencsik T, Böszörményi A, Kocsis B, Horváth G. Antibacterial activity evaluation of selected essential oils in liquid and vapor phase on respiratory tract pathogens. BMC Complementary and Alternative Medicine. 2018;18:227.
Researchers compared several essential oils, including Cinnamon Bark and Eucalyptus globulus, against respiratory-tract bacteria in both liquid and vapor-phase laboratory systems. Cinnamon Bark was one of the strongest oils tested and was particularly active in the vapor-phase assay. Eucalyptus globulus, by contrast, showed comparatively weak antibacterial activity against the tested organisms. That distinction is useful to the formulation logic: Cinnamon contributes documented laboratory antimicrobial activity, while Eucalyptus should not be presented as the antimicrobial engine of Clear Passage™ merely because it is associated with respiratory use — its stronger rationale here is its cineole-rich chemistry and penetrating respiratory character. This was an in-vitro study, not a human treatment trial, and it does not establish that diffusing Clear Passage™ prevents or treats respiratory infection.
[Add DOI/link when available.]
The information provided on this page has not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
